Over 60 years of combined executive leadership experience with a forward-thinking, collaborative approach. Catalysts for transformational change with a history of turning around struggling operations, revitalizing underperforming teams, and driving new levels of quality, efficiency, growth, and profitability. Recognized as authorities in specialty & infusion services including regulatory compliance, use of data to improve outcomes & support decision making, clinical services, and infrastructure design & build.
Marc Stranz, PharmD, has worked for more than 30 years in sterile pharmacy compounding and was an early leader in the home infusion industry.
His work is part of the core practice standards of the industry established by professional organizations and regulatory bodies as well as the body of policy and procedure used by specialty infusion organizations.
Marc Stranz, PharmD, has held branch, regional, and corporate positions with several national providers, including Senior Vice President for Clinical and Strategic Operations at Coram and Vice President of Clinical Operations and Regulatory Affairs at BioScrip. He was also Corporate Director of Infusion Services for Omnicare and Chief Clinical Officer for BioScrip Specialty Services. He was Vice President of Clinical and Compliance for Elwyn Pharmacy Group, and is now the Chief Clinical Officer for BioMatrix Specialty Pharmacy. Dr Stranz pioneered safe and efficient provision of advanced infusion therapies at home and has sustained involvement in cutting-edge therapies. His expertise includes clinical and operational services, regulatory compliance, accreditation, sterile compounding, and design/build of cleanrooms and infusion facilities. Marc was an early Joint Commission pharmacy surveyor, has taken two national specialty pharmacies through three URAC surveys, and is currently an ACHC surveyor. Dr Stranz speaks regularly at national clinical meetings on a variety of topics, publishes frequently, and serves on several professional committees.
Seasoned Healthcare Executive with over 23 years of experience in business development, progressive industry leadership, and complex project management.
Extensive experience in healthcare consulting, change management, and new program development and implementation.
Mala Crossley, PharmD, has held branch, regional, and corporate positions with national long term care, home infusion, and specialty pharmacy providers. She began her career at St Jude Children’s Hospital working in investigational drug studies. After several years in hospital practice, she joined Accredo Specialty Pharmacy, and then moved to BioScrip as Manager of their Kansas City pharmacy. Recognized for her skill, she held the position of National Director of Clinical Operations for BioScrip for several years. To expand her skill set on the payer side of infusion services, Mala joined CareCentrix as Senior Director of Business and Protocol Development for CareCentrix. Most recently, Mala was Vice President, Payer Relations for Elwyn Pharmacy Group, acquired by BioMatrix Specialty Pharmacy. Dr Crossley’s background includes serving as a corporate leader for specialty pharmacy and home infusion services, development of a sophisticated specialty infusion outcome reporting system in 2011, creation of home infusion cost reduction programs for insurers, and expansion of a specialty pharmacy business nationally. Her expertise is in clinical and operational pharmacy services, sterile compounding, and accreditation as well as payer programs for clinical outcomes, site of service, and efficient provision of care. She held corporate level responsibility for URAC accreditation, was a surveyor for HQAA, and is now surveying for ACHC. Mala is on committees with NHIA and NASP and speaks at national meetings on a variety of topics.